An approach to evaluating for fibrosis in patients with metabolic dysfunction-associated steatotic liver disease (MASLD)

This figure summarizes an approach to evaluating for fibrosis in patients with MASLD. This algorithm is intended for use in conjunction with UpToDate content on the clinical features and diagnosis of MASLD. We use ultrasound-based elastography to evaluate for advanced fibrosis or cirrhosis. If imaging methods are not available, alternatives include serologic tests. Refer to UpToDate content on noninvasive assessment of hepatic fibrosis for details.